| RGLS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the RGLS shares outstanding history going back to 10/3/2012:
Also see: RGLS Market Cap History RGLS YTD Return |
RGLS Shares Outstanding History — Regulus Therapeutics Share Count Over Time
As of 5/2/2025 Regulus Therapeutics has 69.23 million RGLS shares outstanding. Investors often track the RGLS shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RGLS share count trends over time, with 53 historical shares outstanding datapoints presented, dating back to 10/3/2012.
| RGLS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RGLS Historical Shares Outstanding: +60.39% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RGLS Stock Price Chart |
| About Regulus Therapeutics Inc |
| Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company. Co. is focused on discovering and developing drugs targeting microRNAs to treat diseases with significant unmet medical need. Co. is focused on orphan kidney diseases where microRNA genetic drivers are implicated and there are clear unmet medical needs. Its product candidate, RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), is in Phase 1b clinical development. We show 53 historical shares outstanding datapoints in our coverage of RGLS's shares outstanding history. Understanding the changing numbers of RGLS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RGLS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RGLS by allowing them to research RGLS shares outstanding history as well as any other stock in our coverage universe. |
| RGLS Current Stock Quote |
Quotes delayed 20 minutes  Free RGLS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| RGLS Share Performance |
| Shares Outstanding Peers |
| Regulus Therapeutics (RGLS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RGNX Shares Outstanding History RIGL Shares Outstanding History RLAY Shares Outstanding History RLMD Shares Outstanding History RLYB Shares Outstanding History RMD Shares Outstanding History RMED Shares Outstanding History RMTI Shares Outstanding History RNA Shares Outstanding History RNAC Shares Outstanding History More Healthcare companies » |
RGLS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
